| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |